POLYMORPHIC MODIFICATION IN N-{5-[3-(THIOPHENE-2-CARBONYL)-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL]-2-FLUORO-PHENYL}-N-METHYL-ACETAMIDE (VERSIONS), CONTAINING IT PHARMACEUTICAL COMPOSITION (VERSIONS), MEDICATION, METHOD OF OBTAINING SAID POLYMORPHIC MODIFICATION (VERSIONS) AND METHOD OF TREATMENT AND/OR PREVENTION OF NERVOUS DISORDERS Russian patent published in 2011 - IPC C07D487/04 A61K31/519 A61P25/08 A61P25/20 A61P25/22 

Abstract RU 2413729 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed invention describes novel polymorphic modification N-{5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-2-fluoro-phenyl}-N-methyl-acetamide, methods of its obtaining, its application as medication, its application for preparation of medication and pharmaceutical compositions, including novel polymorphic modification.

EFFECT: obtaining novel polymorphic modification for preparation of medication and pharmaceutical compositions.

30 cl, 2 tbl, 24 ex, 7 dwg

Similar patents RU2413729C2

Title Year Author Number
METHOD OF PRODUCING N-{5-[3-(THIOPHENE-2-CARBONYL)-PYRAZOLE[1,5-a]PYRIMIDIN-7-YL]-2-FLUORO-PHENYL}-N-METHYL-ACETAMIDE IN POLYMORPHIC MODIFICATION B 2007
  • Anglada Luis
  • Gul'Etta Antonio
  • Palomer Al'Bert
RU2404984C1
HALOGENISED PYRAZOLO[1,5-a]PYRIMIDINES (VERSIONS), METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND METHOD FOR PREPARING THEM (VERSIONS) 2006
  • Anglada Luis
  • Gul'Etta Antonio
  • Palomer Al'Bert
RU2478101C2
AMORPHOUS FORM OF N-{2-FLUORINE-5-[3-(THIOPHEN-2-CARBONYL)-PIRAZOLO[1,5-a]-PYRIMIDIN-7-YL]-PHENYL)-N-METHYL-ACETAMIDE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION (VERSIONS) CONTAINING SAID AMORPHOUS FORM AND DRUG AND METHOD OF TREATING AND/OR PREVENTING NERVOUS DISORDERS 2007
  • Anglada Luis
  • Gul'Etta Antonio
  • Palomer Al'Bert
RU2450005C2
N-(5-ACETYL-2-FLUOROPHENYL)-N-METHYLACETAMIDE, METHOD OF PRODUCING N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUOROPHENYL]-N-METHYLACETAMIDE AND METHOD OF PRODUCING N-{2-FLUORO-5-[3-THIOPHENE-2-CARBONYL-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL]PHENYL}-N-METHYLACETAMIDE 2010
  • Markil'Jas Fransisko
  • Sal'Jares Rosel' Khuan
RU2503655C2
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION SHOWING ABILITY TO INHIBIT GABA RECEPTORS, AND DRUG FOR TREATING AND PREVENTING DISORDERS ASSOCIATED WITH GABA RECEPTOR INHIBITION 2007
  • Anglada Luis
  • Gul'Etta Antonio
  • Palomer Al'Bert
RU2458063C2
IBANDRONATE POLYMORPH B 2006
  • Ajermann Uve
  • Jungkhans Bernd
  • Knipp Bernkhard
  • Zattel'Kau Tim
RU2387661C2
METHOD OF SYNTHESIS OF n-ARYLPIPERAZINE ALKANEAMIDE DERIVATIVES 1988
  • Zhorzh Anri Pol' Van Dal'[Be]
  • Freddi Fransua Vlamink[Be]
  • Mark Gustaf Selin Verdonk[Be]
RU2014328C1
POLYMORPHIC FORMS 2013
  • Numata Tojokharu
  • Aoyama Khideuki
  • Muradzi Kaori
RU2659036C2
TRICYCLIC DERIVATIVES OF PYRAZOLE, PHARMACEUTICAL COMPOSITION 1998
  • Maeno Kioiti
  • Kazuta Ken-Iti
  • Kubota Khideki
  • Simada Itsuro
  • Kimizuka Tetsuja
  • Sakamoto Suiti
  • Vanibuti Fumikazu
RU2191176C2
POLYMORPHIC MODIFICATION OF A IBANDRONATE 2006
  • Ajermann Uve
  • Jungkhans Bernd
  • Knipp Bernkhard
  • Zattel'Kau Tim
RU2368617C2

RU 2 413 729 C2

Authors

Anglada Luis

Gul'Etta Antonio

Palomer Al'Bert

Dates

2011-03-10Published

2007-10-10Filed